Omid Pajand
About
In The Last Decade
Omid Pajand
22 papers receiving 407 citations
Peers
Comparison fields: 5 of 56
- Molecular Medicine 304
- Endocrinology 153
- Molecular Biology 99
- Epidemiology 98
- Infectious Diseases 80
Countries citing papers authored by Omid Pajand
This map shows the geographic impact of Omid Pajand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omid Pajand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omid Pajand more than expected).
Fields of papers citing papers by Omid Pajand
This network shows the impact of papers produced by Omid Pajand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omid Pajand. The network helps show where Omid Pajand may publish in the future.
Co-authorship network of co-authors of Omid Pajand
This figure shows the co-authorship network connecting the top 25 collaborators of Omid Pajand. A scholar is included among the top collaborators of Omid Pajand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omid Pajand. Omid Pajand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 4 | |
| 3 | 0 | |
| 4 | 9 | |
| 5 | 6 | |
| 6 | 2 | |
| 7 | 37 | |
| 8 | 18 | |
| 9 | 27 | |
| 10 | 9 | |
| 11 | 17 | |
| 12 | 39 | |
| 13 | 45 | |
| 14 | 44 | |
| 15 | 30 | |
| 16 | 25 | |
| 17 | Detection of Epstein- Barr virus infection in lymphoma: ELISA and PCR method | 1 |
| 18 | 5 | |
| 19 | 69 | |
| 20 | Comparison of HCMV DNA load and antigenemia results in hematopoietic transplant recipients based on GVHD grade | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.